Botulax 100unit

Botulax 100 Unit – Precision Botulinum Toxin Type A

Botulax 100 Unit is a refined botulinum toxin type A formulation for professional aesthetic practice, offering predictable performance, clear labeling, and batch-level traceability for confident use across common treatment areas.

Key Highlights

• 100-unit vial sized for routine facial aesthetic procedures
• Refined purification for consistent diffusion and potency
• Manufactured under GMP standards with documented batch traceability
• Clear vial and carton labeling to streamline clinical inventory
• Flexible dilution protocols per official guidance to fit varied treatment plans

Intended Use

For administration by licensed medical professionals in accordance with local regulations and clinical best practices. Common aesthetic areas include glabellar lines, forehead, and periorbital regions, following approved indications and patient-specific assessment.

Composition

• Active: Botulinum toxin type A, 100 units per vial
• Excipients: Human serum albumin, sodium chloride
• Preservatives: None

Package Contents

• 1 × 100-unit vial of Botulax (botulinum toxin type A)
• Sealed carton with lot number and expiry for traceability

Storage & Handling

• Store refrigerated as directed on the product label
• Protect from light and temperature excursions
• Do not use if packaging is damaged or if the vial shows particulate matter after reconstitution

Reconstitution & Administration

For professional use only. Reconstitute with sterile, preservative-free 0.9% sodium chloride using aseptic technique. Gently mix without shaking vigorously. Inspect the solution before use. Follow the official prescribing information for dilution volumes, dosing, injection technique, and anatomical considerations. Discard any unused reconstituted solution according to local regulations.

Quality & Traceability

• Produced under GMP with lot-level documentation
• Consistent potency and diffusion profile to support predictable outcomes
• Batch and expiry clearly marked for audit and inventory control

Safety Information

• Contraindicated in patients with known hypersensitivity to botulinum toxin or formulation components
• Do not inject into areas with active infection or inflammation
• Use caution in patients with neuromuscular disorders; monitor for signs of toxin spread
• Counsel patients on expected effects, onset, and possible adverse reactions per official guidance

Professional Reminder

This product is intended for administration by trained healthcare providers. Always review and follow the full prescribing and safety information supplied with the product and comply with local regulatory requirements.

See also: Accessories · Eva Solo

Reference: Official source.

See also: Accessories